Horobin Joanna — SEC Form 4 filings

SEC reporting owner CIK 1560959. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-07 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kymera Therapeutics, Inc. (KYMR)Director12 legs · 8,500 sh · $280,4002
Liquidia Corp (LQDA)Director41 leg · 5,000 sh · $135,8503

Form 4 filings — Horobin Joanna

FiledFormIssuerReported transactionsSource
2026-06-184Liquidia Corp (LQDA)Grant/award (A): 5,882 @ $0EDGAR
2025-08-214Liquidia Corp (LQDA)Sale (S): 5,000 @ $27.17EDGAR
2025-06-204Liquidia Corp (LQDA)Grant/award (A): 18,396 @ $0EDGAR
2024-06-244Liquidia Corp (LQDA)Grant/award (A): 20,359 @ $0EDGAR
2024-06-074Kymera Therapeutics, Inc. (KYMR)Option exercise (M): 8,500 @ $2.08 · Sale (S): 2,187 @ $32.65 · Sale (S): 6,313 @ $33.11 · Option exercise (M): 8,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1560959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →